SJP Project Solutions Announces Completion of Eisai’s 300,000-SF Purpose-Built Headquarters in Nutley, NJ

December 7, 2022 | Press Release

NUTLEY, N.J. – SJP Project Solutions — the third-party construction and project management arm of owner and developer SJP Properties — has completed its build-out of Eisai’s new U.S. headquarters at ON3, a high-tech bio-ecosystem in Nutley, New Jersey. Eisai, an oncology and neurology-focused pharmaceutical company and the U.S. subsidiary of Eisai Co., Ltd., has relocated its U.S. headquarters from Woodcliff Lake, taking the entirety of 200 Metro Boulevard at ON3.

“New Jersey has a long history of serving  s an incubator for some of the most innovative companies in the pharmaceutical and life science spaces and Eisai’s new headquarters at ON3 will set the standard for the future of the industry’s workplaces,” said Andrew Natale, Chief Operating Officer at SJP Project Solutions. “We are proud to have helped deliver a best-in-class headquarters that will support Eisai’s peerless standard of research and development, as well as its relentless focus on promoting teamwork, safety and innovation in the office.”

Eisai signed a lease for 300,000 square feet at the campus in August 2020 and tapped SJP Project Solutions to spearhead its delivery in conjunction with its in-house team. As part of this process, Project Solutions collaborated with ON3 owner Prism Capital Partners on the base-building improvements and worked closely with leading global architecture firms HLW and AMA on the design and build-out of the space. Eisai’s staff of approximately 1,200 corporate and R&D workers transferred to the new headquarters in Q1 of 2022.

SJP’s Project Solutions division has years of experience not just delivering superior, complex construction projects, but also specifically in creating resilient, ideal headquarters locations for international companies across the New York Metro area. Since its launch in 2018, the division has grown to include assignments totaling over 2 million square feet of build-out and ground-up construction projects. Notable projects include the redevelopment of CSG’s headquarters in Roseland, N.J.; the complete renovation of McCarter & English’s office at Gateway Center in Newark, N.J.; the repositioning of Veris Residential’s Harborside mixed-use development along the waterfront in Jersey City, N.J.; the build-out of EY’s offices in Hoboken, N.J.; the development of Prudential Financial’s headquarters in Newark, N.J.; and the development of Life Time Work’s office in Bridgewater, N.J.

To learn more about SJP Project Solutions and its third-party management offerings, visit www.sjpprojectsolutions.com.

About Eisai Inc.

At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and help to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at https://us.eisai.com and follow us on Twitter and LinkedIn.

About SJP Properties

Headquartered in New York City, SJP Properties is a vertically integrated commercial and residential real estate owner, developer, investor, asset manager, construction manager and property manager. The expertise of the company’s core in-house team of professionals encompasses the entire development process, from site selection through coordination of tenant move-in for large multi-phase projects, including numerous Class A build-to-suit developments and individual tenant build-outs. Well known for the creation of unparalleled lifestyle-focused developments, SJP is committed to meticulous design and engineering development plans that reflect a keen understanding of market demand.

Having sustained an unblemished track record of success, SJP has established relationships with many of the industry’s leading investors and financial institutions, providing unparalleled access to capital. For more information, call 212-335-2200, visit www.sjpproperties.com or follow us on LinkedIn and Instagram.